JP2005519934A - エリスロマイシン誘導体の非水和物／水和物およびその非水和物／水和物を製造する方法 - Google Patents

エリスロマイシン誘導体の非水和物／水和物およびその非水和物／水和物を製造する方法 Download PDF

Info

Publication number
JP2005519934A
JP2005519934A JP2003567919A JP2003567919A JP2005519934A JP 2005519934 A JP2005519934 A JP 2005519934A JP 2003567919 A JP2003567919 A JP 2003567919A JP 2003567919 A JP2003567919 A JP 2003567919A JP 2005519934 A JP2005519934 A JP 2005519934A
Authority
JP
Japan
Prior art keywords
hydrate
hemifumarate
compound
ray diffraction
crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003567919A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005519934A5 (enExample
Inventor
謙次 鎌田
暁 平出
嘉一郎 小山
清水　　仁
ワード，ゲイリー・エイチ
チェルヴァルラス，ヴァンダナ・ケイ
ペアレント，ステファン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of JP2005519934A publication Critical patent/JP2005519934A/ja
Publication of JP2005519934A5 publication Critical patent/JP2005519934A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP2003567919A 2002-01-11 2003-01-14 エリスロマイシン誘導体の非水和物／水和物およびその非水和物／水和物を製造する方法 Pending JP2005519934A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002004680 2002-01-11
JP2002076708 2002-03-19
PCT/JP2003/000203 WO2003068793A1 (en) 2002-01-11 2003-01-14 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate

Publications (2)

Publication Number Publication Date
JP2005519934A true JP2005519934A (ja) 2005-07-07
JP2005519934A5 JP2005519934A5 (enExample) 2006-03-02

Family

ID=27736409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003567919A Pending JP2005519934A (ja) 2002-01-11 2003-01-14 エリスロマイシン誘導体の非水和物／水和物およびその非水和物／水和物を製造する方法

Country Status (7)

Country Link
US (1) US20050176938A1 (enExample)
EP (1) EP1463743A1 (enExample)
JP (1) JP2005519934A (enExample)
AU (1) AU2003202137A1 (enExample)
CA (1) CA2472603A1 (enExample)
TW (1) TW200302830A (enExample)
WO (1) WO2003068793A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009514714A (ja) * 2003-06-26 2009-04-09 コンチネンタル・テベス・アーゲー・ウント・コンパニー・オーハーゲー スリップ制御ブレーキシステム用液圧ユニット

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141769B2 (en) * 2005-04-01 2006-11-28 Cem Corporation Spectroscopy-based real-time control for microwave-assisted chemistry

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09100291A (ja) * 1995-08-03 1997-04-15 Chugai Pharmaceut Co Ltd エリスロマイシン誘導体の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY113693A (en) * 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
ZA966601B (en) * 1995-08-03 1997-02-19 Chugai Pharmaceutical Co Ltd Process for producing erythromycin derivatives.
US5945405A (en) * 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
SK142000A3 (en) * 1997-07-08 2000-06-12 Biochemie Sa Erythromycin a oxime solvates

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09100291A (ja) * 1995-08-03 1997-04-15 Chugai Pharmaceut Co Ltd エリスロマイシン誘導体の製造方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009514714A (ja) * 2003-06-26 2009-04-09 コンチネンタル・テベス・アーゲー・ウント・コンパニー・オーハーゲー スリップ制御ブレーキシステム用液圧ユニット

Also Published As

Publication number Publication date
TW200302830A (en) 2003-08-16
US20050176938A1 (en) 2005-08-11
AU2003202137A1 (en) 2003-09-04
EP1463743A1 (en) 2004-10-06
CA2472603A1 (en) 2003-08-21
WO2003068793A1 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
EP2785702B1 (en) Crystalline dapagliflozin hydrate
RU2615509C2 (ru) Кристаллическая 7-{ (3s,4s)-3-[(циклопропиламино)метил]-4-фторпирролидин-1-ил} -6-фтор-1-(2-фторэтил)-8-метокси-4-оксо-1,4-дигидрохинолин-3-карбоновая кислота
HU230717B1 (hu) Eljárás a 4"-es helyzetben szubsztituált 9-dezoxo-9a-aza-9a-homoeritromicin-A-származékok előállítására
TWI585092B (zh) 晶狀（１ｒ，４ｒ）－６’－氟基－Ｎ，Ｎ－二甲基－４－苯基－４’，９’－二氫－３’Ｈ－螺［環己烷－１，１’－吡喃［３，４，ｂ］吲哚］－４－胺
WO2015181573A1 (en) Dasatinib salts
WO2003097650A1 (en) Methods for preparation of olanzapine polymorphic form i
CZ2014502A3 (cs) Nová forma sofosbuviru a způsob její přípravy
KR20220118525A (ko) 벤즈이미다졸 유도체
JP2011530487A (ja) バリオールアミンの立体選択的合成を行うための物質及び方法
WO2017125772A1 (en) Baricitinib salts
WO2007013086A1 (en) Novel polymorphs of tenofovir disoproxil fumarate
CN117327070A (zh) 一种含氮桥杂环衍生物的晶型及其制备方法
JP2022523035A (ja) １，２，３－トリアゾロ［１，５－ａ］ピラジン誘導体の結晶形および結晶形の調製方法
CZ306623B6 (cs) Soli abirateronu acetátu
JP2005519934A (ja) エリスロマイシン誘導体の非水和物／水和物およびその非水和物／水和物を製造する方法
CA2648369A1 (en) Polymorphic forms of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4?l)-1-oxo-2,6-dihydro-1h-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide
ES2295663T3 (es) Gamma-lactona cristalina de acido 17beta-hidroxi-7alfa-(5'-metil-2' -furil)-pregna-4,9(11)-dien-3-ona-21-carboxilico.
JP2005519934A5 (enExample)
KR20120053027A (ko) 페소테로딘 푸마레이트 및 페소테로딘 염기의 결정형
EP3912985A1 (en) Crystal forms of antidepressant drug sage-217 and preparation method therefor
US9221870B2 (en) Crystal form of an organic compound and process for the preparation thereof
JP2020535192A (ja) レナリドミドの結晶形
CN117480170A (zh) 用于合成缬苯那嗪的方法
WO2025029842A2 (en) Process of making 2-[(3r)-2-[4-amino-3-(2-fluoro-4-phenoxy- phenyl)pyrazolo[3,4-d]pyrimidin-l-yl]piperidine-l-carbonyl]-4- methyl-4[4-(oxetan-3-yl)piperazin-l-yl]-pent-2-enenitrile and solvate forms thereof
KR20250107260A (ko) 2-(4-(2-(7,8-디메틸-[1,2,4]트리아졸로[1,5-a] 피리딘-6-일)-3-이소프로필-1H-인돌-5-일)피페리딘-1-일)아세트아미드 염 및 그의 결정질 형태

Legal Events

Date Code Title Description
A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20060116

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20060116

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090925

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100405